-
A Budget Impact Model of Switching From Self-Monitoring of Blood Glucose to Continuous Glucose Monitoring for Individuals With Type 2 Diabetes Mellitus Receiving Basal Insulin in Italy
Sep 9, 2025, 16:22 PM -
The Impact of the Introduction of Diagnosis-Related Groups (DRG)-Based Hospital Financing on the Performance of Romanian Hospitals
Sep 9, 2025, 16:22 PM -
Components of the Direct Cost of Topical Treatment for Chronic Wounds in Adults and Elderly: A Systematic Review
Sep 9, 2025, 16:22 PM -
Distributional Cost-Effectiveness Analysis Across the Globe: How Feasible Is It Really?
Sep 9, 2025, 16:22 PM -
Evaluating the Lifetime Incremental Value of Pharmaceutical Innovation: The Case of Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Exploratory Assessment of the Societal Impact of Changing Informal Care Hours in the Netherlands
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Immune Checkpoint Inhibitors Chemotherapy (ICI+CT) vs. ICI Monotherapy (ICI) in Untreated Locally Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Societal Value of Intravitreal Injections for Retinal Vascular Diseases in the National Reimbursement Drug List in China
Sep 9, 2025, 16:22 PM -
Comparative Cost-Effectiveness Analysis of Isavuconazole vs. Liposomal Amphotericin B for the Treatment of Invasive Mucormycosis in Algerian Hospital Setting
Sep 9, 2025, 16:22 PM -
Improving the Transferability of Global RCT Data to Inform Cost-Effectiveness Models in Japan: A Structured Framework for C2H Submissions
Sep 9, 2025, 16:22 PM -
The Changing Prevalence of Multicomorbid Patients in the US
Sep 9, 2025, 16:22 PM -
Evolving Assumptions on Treatment Durability in Cost-Effectiveness Models of Cell and Gene Therapies: Insights From French HTA Submissions
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Intensive and Emerging Rehabilitation Therapies in Children With Cerebral Palsy: Real-World Evidence and Microsimulation Modeling
Sep 9, 2025, 16:22 PM -
PROMOD Study: Forecasting the Dialysis Burden in Morocco and the Cost-Avoidance Potential of Optimal Nephroprotection: A Markov-Based Economic Model
Sep 9, 2025, 16:22 PM -
Understanding the Consequences of International Reference Pricing on Cancer Immunotherapy in Europe: A 10-Year Price Corridor Analysis
Sep 9, 2025, 16:22 PM -
Sex Differences in Characteristics and Treatment Patterns of Patients With Sleep Disorders in South Korea
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Cefiderocol for the Treatment of Confirmed MBL-Producing Pathogens in Italy
Sep 9, 2025, 16:22 PM -
Constructing a Dynamic Budget Impact Model: An AI Pretraining Approach for a New Parkinson's Disease Drug
Sep 9, 2025, 16:22 PM -
Understanding Awareness Obstacles and Facilitators of Generic Medication Substitution Among Healthcare Professionals in Pakistan: A Qualitative Study
Sep 9, 2025, 16:22 PM -
Estimating Health Utility Decrements Associated With Chronic Disease Outcomes Using MEPS
Sep 9, 2025, 16:22 PM